Impact of SPARC expression on pembrolizumab treatment response and prognostic role in advanced stage non-small cell lung cancer
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Lippincott Williams & Wilkins
Access Rights
info:eu-repo/semantics/closedAccess
DOI
Abstract
Description
Keywords
Journal or Series
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
WoS Q Value
Scopus Q Value
Volume
41
Issue
16
Citation
Göktaş Aydın, S., Bilici, A., Çalış, E., Ölmez, Ö. F. ve Karcı, E. (2023). Impact of SPARC expression on pembrolizumab treatment response and prognostic role in advanced stage non-small cell lung cancer. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). Chicago, IL, 02-06 June 2023.
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
info:eu-repo/semantics/closedAccess
